Jay Gargus, “Autism: A Genetic Perspective” (Open Agenda, 2021)
New Books in Neuroscience
00:00
Rare Diseases - Is There a Mechanism to Get FDA Approval?
The fda has become quite responsive a, specifically in the context of what are called rare diseases. The drug companies aren't going to partner with you until you can sort of show them that you have some kinds of efficacies. I think ono a lot of the stuff that we get just completely burdened with hemn just being able to get all of the institutional review board things,. In order to carry out or clinical trials, takes like a her. It takes a long time to go through all those who ie. So it would be nice to find a simpler mechanism to make what's an approval process at one institution work in another institution.
Transcript
Play full episode
